Effect of Antacids on the Pharmacokinetics of Raltegravir
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test whether there is a drug interaction between raltegravir
(a medicine used to treat the human immunodeficiency virus or HIV) and antacids.
Phase:
Phase 1
Details
Lead Sponsor:
University of Colorado, Denver
Treatments:
Aluminum hydroxide, magnesium hydroxide, simethicone drug combination Antacids Anti-Ulcer Agents Raltegravir Potassium TEMPO